Grignon D J, el-Naggar A, Green L K, Ayala A G, Ro J Y, Swanson D A, Troncoso P, McLemore D, Giacco G G, Guinee V F
Department of Pathology, University of Texas, M. D. Anderson Hospital Cancer Center, Houston, 77030.
Cancer. 1989 Mar 15;63(6):1161-5. doi: 10.1002/1097-0142(19890315)63:6<1161::aid-cncr2820630620>3.0.co;2-n.
The features most frequently used in predicting the outcome of renal cell carcinoma are stage at presentation and nuclear grade. Recently DNA ploidy pattern, as detected by DNA flow cytometry has also been shown to be predictive. In this study DNA flow cytometry was performed on formalin-fixed paraffin-embedded tissue from 50 patients with Stage I renal cell carcinoma for whom long-term follow-up data were available. Two were eliminated for technical reasons. Of the 48 evaluable tumors, 25 (52%) were diploid, 19 (40%) were nondiploid, and in four, (8%) the ploidy was uncertain. The ploidy pattern was statistically significantly associated with nuclear grade (P less than 0.02), and primary tumor size (P less than 0.05) but did not correlate with cell type, microscopic growth pattern, or the presence or absence of mitotic activity. In the group as a whole, ten patients (21%) died of renal cell carcinoma, seven of 19 (37%) with nondiploid tumor patterns, and two of 25 (8%) with a diploid pattern (P less than 0.03). One of four patients (25%) with tumors of uncertain ploidy also died. However, only two factors, nuclear grade and primary tumor size, were independent predictors of outcome. For Stage I renal cell carcinoma, ploidy can significantly predict patient outcome and correlates with nuclear grade and tumor size, but is not an independent predictive variable.
预测肾细胞癌预后最常用的特征是就诊时的分期和核分级。最近,通过DNA流式细胞术检测到的DNA倍体模式也已被证明具有预测性。在本研究中,对50例I期肾细胞癌患者的福尔马林固定石蜡包埋组织进行了DNA流式细胞术检测,这些患者均有长期随访数据。因技术原因排除2例。在48例可评估肿瘤中,25例(52%)为二倍体,19例(40%)为非二倍体,4例(8%)倍体情况不确定。倍体模式与核分级(P<0.02)和原发肿瘤大小(P<0.05)在统计学上显著相关,但与细胞类型、显微镜下生长模式或有丝分裂活性的有无无关。在整个研究组中,10例患者(21%)死于肾细胞癌,19例非二倍体肿瘤模式患者中有7例(37%)死亡,25例二倍体模式患者中有2例(8%)死亡(P<0.03)。4例倍体情况不确定的患者中有1例(25%)也死亡。然而,只有两个因素,即核分级和原发肿瘤大小,是预后的独立预测因素。对于I期肾细胞癌,倍体可显著预测患者预后,并与核分级和肿瘤大小相关,但不是一个独立的预测变量。